Accordingly, the ALT/AST ratio is associated with NAFLD in the general population, and it may be a useful diagnostic indicator of NAFLD, according to an increasing amount of clinical research (41). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.